• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines.

作者信息

Bovelli D, Plataniotis G, Roila F

机构信息

Department of Cardiology, Santa Maria Hospital, Terni, Italy.

出版信息

Ann Oncol. 2010 May;21 Suppl 5:v277-82. doi: 10.1093/annonc/mdq200.

DOI:10.1093/annonc/mdq200
PMID:20555097
Abstract
摘要

相似文献

1
Cardiotoxicity of chemotherapeutic agents and radiotherapy-related heart disease: ESMO Clinical Practice Guidelines.化疗药物的心脏毒性与放疗相关心脏病：ESMO临床实践指南
Ann Oncol. 2010 May;21 Suppl 5:v277-82. doi: 10.1093/annonc/mdq200.
2
[Effects of radiotherapy and chemotherapy on the heart and pericardium in patients with lymphogranulomatosis].[放疗和化疗对淋巴肉芽肿病患者心脏和心包的影响]
Kardiologiia. 1991 Feb;31(2):75-8.
3
[Cardiotoxicity of Hodgkin's disease therapy].[霍奇金病治疗的心脏毒性]
Vnitr Lek. 2003 Jan;49(1):21-2.
4
[Cardiac pathology in patients after therapy for Hodgkin's lymphoma].[霍奇金淋巴瘤治疗后患者的心脏病理学]
Vopr Onkol. 2011;57(1):119-25.
5
Cardiac risks in multimodal breast cancer treatment.多模式乳腺癌治疗中的心脏风险
Strahlenther Onkol. 2007 Dec;183 Spec No 2:9-10. doi: 10.1007/s00066-007-2004-7.
6
Cardiac toxicity in breast cancer survivors: review of potential cardiac problems.乳腺癌幸存者的心脏毒性：潜在心脏问题综述
Clin Cancer Res. 2008 Jan 1;14(1):14-24. doi: 10.1158/1078-0432.CCR-07-1033.
7
[Cardiotoxicity as undesired side effect in the treatment of breast cancer].[心脏毒性作为乳腺癌治疗中不良副作用]
Postepy Hig Med Dosw (Online). 2014 May 8;68:483-97. doi: 10.5604/17322693.1101581.
8
NT-proBNP as early marker of subclinical late cardiotoxicity after doxorubicin therapy and mediastinal irradiation in childhood cancer survivors.N-末端脑钠肽前体作为儿童癌症幸存者接受阿霉素治疗和纵隔照射后亚临床晚期心脏毒性的早期标志物。
Dis Markers. 2015;2015:513219. doi: 10.1155/2015/513219. Epub 2015 Apr 16.
9
Dose response in human and experimental radiation-induced heart disease. Application of the nominal standard dose (NSD) concept.人类及实验性辐射诱发心脏病中的剂量反应。标称标准剂量（NSD）概念的应用。
Radiology. 1971 May;99(2):403-8. doi: 10.1148/99.2.403.
10
Heart health after breast cancer.乳腺癌后的心脏健康
Johns Hopkins Med Lett Health After 50. 2009 Dec;21(10):1-2.

引用本文的文献

1
Monitoring high-risk patients for chemotherapy-related cardiotoxicity: A retrospective analysis.监测高危患者的化疗相关心脏毒性：一项回顾性分析。
World J Clin Cases. 2025 Sep 16;13(26):107716. doi: 10.12998/wjcc.v13.i26.107716.
2
Analysis of Cardiotoxicity and Risk Factors of Breast Cancer Chemotherapy Drugs: A Five-Year Single-Centre Retrospective Study in Early Breast Cancer.乳腺癌化疗药物的心脏毒性及危险因素分析：一项针对早期乳腺癌的单中心五年回顾性研究
Drug Des Devel Ther. 2025 Jul 30;19:6505-6517. doi: 10.2147/DDDT.S516457. eCollection 2025.
3
Consensus Guidelines and Recommendations for The CD38 Monoclonal Antibody-based Quadruplet Therapy and Management in Clinical Practice for Newly Diagnosed Multiple Myeloma: From the Pan-Pacific Multiple Myeloma Working Group.
《基于CD38单克隆抗体的四联疗法在新诊断多发性骨髓瘤临床实践中的共识指南与建议：泛太平洋多发性骨髓瘤工作组》
Clin Hematol Int. 2025 Apr 11;7(2):1-19. doi: 10.46989/001c.133682. eCollection 2025.
4
AI and Smart Devices in Cardio-Oncology: Advancements in Cardiotoxicity Prediction and Cardiovascular Monitoring.心脏肿瘤学中的人工智能与智能设备：心脏毒性预测和心血管监测的进展
Diagnostics (Basel). 2025 Mar 20;15(6):787. doi: 10.3390/diagnostics15060787.
5
Assessment of myocardial deformation by CMR tissue tracking reveals left ventricular subclinical myocardial dysfunction in patients with gynecologic cancer undergoing chemotherapy.通过心脏磁共振成像（CMR）组织追踪评估心肌变形，发现接受化疗的妇科癌症患者存在左心室亚临床心肌功能障碍。
Front Oncol. 2025 Feb 3;15:1464368. doi: 10.3389/fonc.2025.1464368. eCollection 2025.
6
Anthracycline-Induced Cardiomyopathy in Cancer Survivors: Management and Long-Term Implications.癌症幸存者中的蒽环类药物所致心肌病：管理与长期影响
Adv Exp Med Biol. 2025;1474:179-199. doi: 10.1007/5584_2024_804.
7
Physical Functional Impairment in Breast Cancer Patients: A Cross-Sectional Expert Survey.乳腺癌患者的身体功能障碍：一项横断面专家调查。
Cureus. 2024 Mar 31;16(3):e57364. doi: 10.7759/cureus.57364. eCollection 2024 Mar.
8
Practical management of disease-related manifestations and drug toxicities in patients with multiple myeloma.多发性骨髓瘤患者疾病相关表现及药物毒性的实际管理
Front Oncol. 2024 Mar 22;14:1282300. doi: 10.3389/fonc.2024.1282300. eCollection 2024.
9
Evaluating a Remotely Delivered Cardio-Oncology Rehabilitation Intervention for Patients With Breast Cancer (REMOTE-COR-B): Protocol for a Single-Arm Feasibility Trial.评估乳腺癌患者远程心脏肿瘤康复干预措施（REMOTE-COR-B）：单臂可行性试验方案
JMIR Res Protoc. 2024 Apr 5;13:e53301. doi: 10.2196/53301.
10
Incidence of MACE in Patients Treated With CAR-T Cell Therapy: A Prospective Study.接受CAR-T细胞疗法治疗的患者中主要不良心血管事件的发生率：一项前瞻性研究。
JACC CardioOncol. 2023 Oct 10;5(6):747-754. doi: 10.1016/j.jaccao.2023.07.009. eCollection 2023 Dec.